About: The Brighton collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Brighton collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The Brighton collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
Creator	Smith, Emily Excler, Jean-Louis Gurwith, Marc Kim, Denny Kochhar, Sonali Wood, David Smith, Jonathan Robertson, James Condit, Richard Fast, Patricia Monath, Thomas Pavlakis, George Chen, Robert
Source	Elsevier; Medline; PMC
abstract	Nucleic acid (DNA and RNA) vaccines are among the most advanced vaccines for COVID-19 under development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of nucleic acid vaccines. This will facilitate the assessment by key stakeholders of potential safety issues and understanding of overall benefit-risk. The structured assessment provided by the template can also help improve communication and public acceptance of licensed nucleic acid vaccines.
has issue date	2020-06-19(xsd:dateTime)
bibo:doi	10.1016/j.vaccine.2020.06.017
bibo:pmid	32571717
has license	no-cc
sha1sum (hex)	29321f88283e9ca70ead01c67e669254d0749ae8
schema:url	https://doi.org/10.1016/j.vaccine.2020.06.017
resource representing a document's title	The Brighton collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
has PubMed Central identifier	PMC7304391
has PubMed identifier	32571717
schema:publication	Vaccine
resource representing a document's body	covid:29321f88283e9ca70ead01c67e669254d0749ae8#body_text
is schema:about of	named entity 'Brighton collaboration' named entity 'vaccines' named entity 'immunogen' named entity 'COVID-19' named entity 'plasmid DNA' named entity 'nucleic acid' named entity 'vaccine' named entity 'RNA vaccine' named entity 'nucleic acid' named entity 'RNA vaccines' named entity 'DNA vaccine' named entity 'Brighton Collaboration' named entity 'immunogen' named entity 'Coalition for Epidemic Preparedness Innovations' named entity 'DNA and RNA' named entity 'DNA vaccines' named entity 'vaccination' named entity 'e.g. Lewis' named entity 'viral vector' named entity 'vaccine' named entity 'vaccination' named entity 'DNA vaccines' named entity 'WHO' named entity 'transgene' named entity 'adverse effects' named entity 'molecule' named entity 'adverse effects' named entity 'intrinsic properties' named entity 'T-cell' named entity 'Medical Subject Headings' named entity 'host cell' named entity 'immune response' named entity 'immunogen' named entity 'clinical studies' named entity 'DNA vaccines' named entity 'antigen' named entity 'vaccine' named entity 'vaccine' named entity 'messenger RNA' named entity 'WHO' named entity 'vaccine' named entity 'peer reviewed' named entity 'COVID-19' named entity 'RNA vaccines' named entity 'RNA vaccine' named entity 'toxicology' named entity 'antigen' named entity 'adverse effects' named entity 'Brighton Collaboration' named entity 'vaccine' named entity 'Brighton Collaboration' named entity 'antigen' named entity 'RNA' named entity 'RNA vaccine' named entity 'PubMed' named entity 'immunogen' named entity 'DNA vaccine' named entity 'toxicity' named entity 'insertional mutagenesis' named entity 'viral vector' named entity 'vaccine' named entity 'Viral Vector' named entity 'RNA vaccines' named entity 'vaccine' named entity 'Ebola' named entity 'Ebola vaccines' named entity 'vaccine' named entity 'vaccine' named entity 'RNA virus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software